ANORO ELLIPTA
GLAXOSMITHKLINE INC
Powder
National Drug Code: 90298
Drug Identification Number: 02418401
Number Of Ais: 2
Ai Group No: 0255171002
Descriptor: POWDER FOR ORAL INHALATION
Dosage Unit: ACT
Ingredient Name: UMECLIDINIUM (UMECLIDINIUM BROMIDE)
Delivery Process
Product information is meant for
Disclaimer
Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"
GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of ANORO ELLIPTA which is also known as and Manufactured by GLAXOSMITHKLINE INC. It is available in strength of 62.5 MCG per ml. Read more
ANORO ELLIPTA is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price. Read less
Packaging and Delivery
Validated Cold Chain Shipment
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
Inquire directly from our website and get 5% off on any medicine!
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
Read moreAbout GNH
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
Read more